AbbVie Named Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team, Launches AbbVie Race to Innovate to Support Immunology Community
AbbVie was named an Official Pharmaceutical Partner of the McLaren Mastercard Formula 1 Team in a multi-year partnership launching at the 2026 United States Grand Prix in Austin. The centerpiece is AbbVie Race to Innovate, a purpose-driven campaign under which AbbVie will donate $10,000 to global charities for every 10 Constructors' Championship points McLaren earns, supporting patient advocacy groups for immune-mediated diseases.
Key figures
- Donation per 10 points usd
- 10000
AI analysis
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.